T Cells Dominate the Local Immune Response Induced by Intralesional IL-2 in Combination with Imiquimod and Retinoid for In-Transit Metastatic Melanoma

被引：6
作者：
Ogawa, Hiromi [1 ,2 ]
Luxardi, Guillaume [1 ]
Kirane, Amanda [3 ]
Kulkarni, Rajan [2 ]
Monjazeb, Arta M. [1 ]
Cheng, Michelle Y. [1 ]
Ma, Chelsea [1 ]
Maverakis, Emanual [1 ]
机构：
[1] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA
[2] Univ Calif Los Angeles, Sch Med, Dept Dermatol, Los Angeles, CA USA
[3] Univ Calif Davis, Sch Med, Dept Surg, Los Angeles, CA USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2018年 / 138卷 / 06期
关键词：
HUMAN-IMMUNODEFICIENCY-VIRUS; INTERLEUKIN-2; THERAPY; EXPANSION; TRIAL;
D O I：
10.1016/j.jid.2017.12.027
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：1442 / 1445
页数：5
相关论文
共 12 条
  • [1] Characterization of CD4+CD25+ regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma
    Cesana, GC
    DeRaffele, G
    Cohen, S
    Moroziewicz, D
    Mitcham, J
    Stoutenburg, J
    Cheung, K
    Hesdorffer, C
    Kim-Schulze, S
    Kaufman, HL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (07) : 1169 - 1177
  • [2] Melanoma, Version 2.2016
    Coit, Daniel G.
    Thompson, John A.
    Algazi, Alain
    Andtbacka, Robert
    Bichakjian, Christopher K.
    Carson, William E., III
    Daniels, Gregory A.
    DiMaio, Dominick
    Ernstoff, Marc
    Fields, Ryan C.
    Fleming, Martin D.
    Gonzalez, Rene
    Guild, Valerie
    Halpern, Allan C.
    Hodi, F. Stephen, Jr.
    Joseph, Richard W.
    Lange, Julie R.
    Martini, Mary C.
    Materin, Miguel A.
    Olszanski, Anthony J.
    Ross, Merrick I.
    Salama, April K.
    Skitzki, Joseph
    Sosman, Jeff
    Swetter, Susan M.
    Tanabe, Kenneth K.
    Torres-Roca, Javier F.
    Trisal, Vijay
    Urist, Marshall M.
    McMillian, Nicole
    Engh, Anita
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (04): : 450 - +
  • [3] Complete regression of subcutaneous and cutaneous metastatic melanoma with high-dose intralesional interleukin 2 in combination with topical imiquimod and retinoid cream
    Garcia, Miki Shirakawa
    Ono, Yoko
    Martinez, Steve R.
    Chen, Steven L.
    Goodarzi, Heidi
    Phan, Tiffany
    Wehrli, Lisa N.
    Miyamura, Yoshinori
    Fung, Maxwell A.
    Maverakis, Emanual
    [J]. MELANOMA RESEARCH, 2011, 21 (03) : 235 - 243
  • [4] Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells
    Klebanoff, CA
    Gattinoni, L
    Torabi-Parizi, P
    Kerstann, K
    Cardones, AR
    Finkelstein, SE
    Palmer, DC
    Antony, PA
    Hwang, ST
    Rosenberg, SA
    Waldmann, TA
    Restifo, NP
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (27) : 9571 - 9576
  • [5] Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus
    Kovacs, JA
    Vogel, S
    Albert, JM
    Falloon, J
    Davey, RT
    Walker, RE
    Polis, MA
    Spooner, K
    Metcalf, JA
    Baseler, M
    Fyfe, G
    Lane, HC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (18) : 1350 - 1356
  • [6] INCREASES IN CD4 T-LYMPHOCYTES WITH INTERMITTENT COURSES OF INTERLEUKIN-2 IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A PRELIMINARY-STUDY
    KOVACS, JA
    BASELER, M
    DEWAR, RJ
    VOGEL, S
    DAVEY, RT
    FALLOON, J
    POLIS, MA
    WALKER, RE
    STEVENS, R
    SALZMAN, NP
    METCALF, JA
    MASUR, H
    LANE, HC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (09) : 567 - 575
  • [7] Metastatic Melanoma - A Review of Current and Future Treatment Options
    Maverakis, Emanual
    Cornelius, Lynn A.
    Bowen, Glen M.
    Phan, Tiffany
    Patel, Falin B.
    Fitzmaurice, Sarah
    He, Young
    Burrall, Barbara
    Duong, Christopher
    Kloxin, April M.
    Sultani, Hawa
    Wilken, Reason
    Martinez, Steve R.
    Patel, Forum
    [J]. ACTA DERMATO-VENEREOLOGICA, 2015, 95 (05) : 516 - 524
  • [8] Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases
    Radny, P
    Caroli, UM
    Bauer, J
    Paul, T
    Schlegel, C
    Eigentler, TK
    Weide, B
    Schwarz, M
    Garbe, C
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 (09) : 1620 - 1626
  • [9] Out-of-Sequence Signal 3 Paralyzes Primary CD4+ T-Cell-Dependent Immunity
    Sckisel, Gail D.
    Bouchlaka, Myriam N.
    Monjazeb, Arta M.
    Crittenden, Marka
    Curti, Brendan D.
    Wilkins, Danice E. C.
    Alderson, Kory A.
    Sungur, Can M.
    Ames, Erik
    Mirsoian, Annie
    Reddy, Abhinav
    Alexander, Warren
    Soulika, Athena
    Blazar, Bruce R.
    Longo, Dan L.
    Wiltrout, Robert H.
    Murphy, William J.
    [J]. IMMUNITY, 2015, 43 (02) : 240 - 250
  • [10] 100% Complete response rate in patients with cutaneous metastatic melanoma treated with intralesional interleukin (IL)-2, imiquimod, and topical retinoid combination therapy: Results of a case series
    Shi, Vivian Y.
    Tran, Khiem
    Patel, Forum
    Leventhal, Jonathan
    Konia, Thomas
    Fung, Maxwell A.
    Wilken, Reason
    Garcia, Miki Shirakawa
    Fitzmaurice, Sarah D.
    Joo, Jayne
    Monjazeb, Arta M.
    Burrall, Barbara A.
    King, Brett
    Martinez, Steve
    Christensen, Scott D.
    Maverakis, Emanual
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 73 (04) : 645 - 654
12